As a result of the revision and discussion of the RHD-DGs during the Board of the Network meeting (13-14 November 2019, Barcelona), a total of 70 RHD-DG has been identified. The Myeloid malignancies subnetwork includes 9 disease groups.
RHD-DGs and disorders included are currently under revision for final approval.
| Diseases Groups and entities included |
|---|
| Mastocytosis |
| Acute myeloid leukemia (Other than Acute promyelocytic leukemia and germline predisposition) |
| Acute promyelocytic leukemia |
| Myelodysplastic syndrome |
| Myeloproliferative neoplasm (Other than Chronic myeloid leukemia and Hypereosinophilic syndrome)* |
| Chronic myeloid leukemia |
| Hypereosinophilic syndrome |
| Myelodysplastic/myeloproliferative disease including CMML |
| Myeloid neoplasms with germline predisposition |
